Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Equinor ASA (EQNR) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Equinor ASATrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Equinor ASA vs Recursion Pharmaceuticals Inc — how do they compare? Equinor ASA trades at $40.93 (market cap $97.58B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Equinor ASA is far larger — about 53.9× Recursion Pharmaceuticals Inc's market cap, and Equinor ASA pays a 3.81% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

EQNRRXRX
Market Cap
$97.58B$1.81B
Sector
EnergyHealth
52-Week High
$42.40$6.79
52-Week Low
$22.41$2.84
Enterprise Value
$106.28B$1.33B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Equinor ASA

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.

Read more on EQNR

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX